GlassScriptPhysician profile
Sylvia Denton
NPI 1205223195
$1,477.48
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.81 · 2022: $515 · 2023: $470 · 2024: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $215.49 | 2023-2024 | Airsupra, Farxiga |
| Sanofi-Aventis U.S. LLC | $197.34 | 2022 | |
| Abbvie INC. | $152.19 | 2022-2024 | |
| Abbott Laboratories | $144.62 | 2024 | Freestyle Libre 3 |
| Novo Nordisk INC | $111.75 | 2022 | |
| Sk Life Science, INC. | $88.40 | 2023 | Xcopri |
| Otsuka America Pharmaceutical, INC. | $85.53 | 2023 | Jynarque |
| Dexcom, INC. | $71.03 | 2022 | |
| Biogen, INC. | $70.94 | 2023 | |
| Glaxosmithkline, LLC. | $67.81 | 2021 | |
| Medtronic, INC. | $66.88 | 2023 | Minimed 780g |
| Grifols USA, LLC | $58.34 | 2024 | Prolastin-C Liquid |
| Amgen INC. | $56.21 | 2024 | Otezla |
| Pfizer INC. | $53.45 | 2023 | |
| Janssen Pharmaceuticals, INC | $37.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.